News
The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...
26m
Medindia on MSNHormone Therapy and Breast Cancer Risk in Young WomenA groundbreaking study by the National Institutes of Health (NIH) is shifting the conversation around hormone therapy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results